Although many functional features tend to overlap between HABP4 and SERBP1, in relation to cancer the data so far point in opposite directions, since SERBP1 has been reported to be over-expressed in several cancer settings, including ovary, breast, colon, prostate, glioblastoma and lung cancer [34]. Here, HABP4 is linked to lung carcinoma.